Live Blood Analysis, Cancer, Heart Disease
In this video, James Privitera spends about 31 minutes speaking on "Live Blood Analysis, Cancer, Heart Disease" at the 31st Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.
About James Privitera
JAMES PRIVITERA, M.D. graduated in 1962 with a B.S. Degree in Biology and Chemistry from Canisius College, Buffalo, New York. Later he took Biochemistry at University of Buffalo Graduate School. He gained research experience at Roswell Park Memorial Institute, Buffalo, New York, but decided to go into medicine. In 1967, he graduated with his M.D. Degree from Creighton University School of Medicine, Omaha, Nebraska, followed by a one year Internal Medicine Internship at Providence Hospital, Seattle, Washington. For the next year he took an Internal Medicine Residency at Presbyterian Hospital, San Francisco, California. From 1969-1970 Dr. Privitera took a Clinical Fellowship in Allergy, Immunology and Rheumatology at Scripps Clinic and Research Foundation, La Jolla, California. From 1970 on he entered a private practice of Allergy and Nutrition and practices in Covina, California. Dr. Privitera has done original scientific research with the dark field microscope, analyzing and identifying 25 factors with various disease conditions and nutritionally deficient states. He has co-authored a book on the subject with Alan Stang, Silent Clots, Life's Biggest Killers.It deals with Lockstep Medicine's Conspiracy to suppress the test that should be done in emergency rooms throughout the world. He may be contacted by calling (626) 966-1618.
Transcription
And we have today some other interesting people who are going to speak also. And that is two people on my right. One who has had ovarian cancer and one who had lymphoma. So they're going to talk also. And my lawyer on the left. It is kind of humorous, and because of them, I need him and another scientist, M.D., DHT, who's written a lot of papers on stealth virus. John Martin, 50 percent of people with cancer have access following and 90 percent of people, people with cancer, with metastatic cancer have access clotting. This is normal cells.
This is red cell sticking together, which is very unusual.
It happens in multiple myeloma and very severe circumstances. And this is red cells stuck together in poor oxygenation. A lot of people with a low hemoglobin don't need blood. They just need the red cells separated with niacin and heparin hydrochloric acid, these kinds of things. And here's real clotting. Kind of looks like oatmeal on a slide. Now, this is a very nonspecific thing.
Clotting. Clotting is caused by migraines. It's it's the migraines basically are the cocktail party cause clotting.
So if you have migraines, much research shows that if you break the clots up with fish oils and magnesium, cayenne pepper, feverfew, other things, these are all on page 10 on my book, which which is which is that I don't even know the number of the booth, but it's out there. But Cancer Control Society has my book.
Fifty five.
Those are two nice numbers. The number of grace. OK. So here's what happens also in our tourist grosses. You have clots in the clots become calcified and therefore becoming plaque again. Clots are involved, which are difficult to see. This is basically called vulnerable plaque. And we treat people for vote bone or plaque. That's the most dangerous kind of plaque. It's called vulnerable plaque. But it it the vulnerable plaque occurs along with the calcified plaque. So you can do these ultrafast CAT scans, as we're going to show later on to show the calcified plaque. And if you have the calcified plaque, you sure as heck have the vulnerable plaque.
So go ahead and treat the vulnerable plaque with these various things that I mentioned. Plus, you can use enzymes to digest plaque. And we're going to show a slide of a patient later on who who got rid of 50 percent of his plaque in two years by doing intravenous colation and other nutrition.
And then I'm going to talk about this is a big clot and you're going to hear more and more. One of the most popular concepts right